login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ABBVIE INC (ABBV) Stock News
USA
- NYSE:ABBV -
US00287Y1091
-
Common Stock
231.39
USD
-0.67 (-0.29%)
Last: 10/21/2025, 8:04:00 PM
231.39
USD
0 (0%)
After Hours:
10/21/2025, 8:04:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ABBV Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: Chartmill
- Mentions:
OXY
APP
EFX
NFLX
...
These S&P500 stocks are gapping in today's session
an hour ago - By: Benzinga
- Mentions:
QCOM
IRDM
PANW
APTV
Qualcomm, Aptiv, Palo Alto And A Health Care Stock On CNBC's 'Final Trades'
15 hours ago - By: The Motley Fool
- Mentions:
VRT
HLT
MA
APP
...
This Florida Fund Is Betting $21 Million on Vertiv as AI Data Center Growth Accelerates
18 hours ago - By: The Motley Fool
- Mentions:
HLT
MA
APP
BKNG
...
Abacus FCF Advisors Bets $16 Million on Hilton Even as Hotel Stock Lags Market
a day ago - By: AbbVie
The Confidence Project by BOTOX® Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients
2 days ago - By: Zacks Investment Research
- Mentions:
AZN
PFE
MRK
Here's What to Expect From AbbVie's Oncology Segment in Q3 Earnings
2 days ago - By: AbbVie
RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor
5 days ago - By: Stocktwits
- Mentions:
NVO
Novo Nordisk Hires US Pharma Veteran After Trump Touts ‘Much Lower’ Prices Of Ozempic
5 days ago - By: AbbVie
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin
9 days ago - By: Benzinga
If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today
9 days ago - By: Zacks Investment Research
- Mentions:
AZN
PFE
LLY
AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff Reprieve
9 days ago - By: Stocktwits
- Mentions:
JGRO
DUHP
AbbVie Stock Rises After FDA Approves Changed Recommendations For Use Of Popular Rinvoq Drug
9 days ago - By: AbbVie
U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease
9 days ago - By: AbbVie
AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors
20 days ago - By: Zacks Investment Research
AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why
20 days ago - By: Bloomberg
- Mentions:
ALNY
BMY
Alnylam Pulls TV Ad After Trump Crackdown on Drug Industry Spots
20 days ago - By: Zacks Investment Research
- Mentions:
ADP
AMGN
Stock Market News for Oct 2, 2025
20 days ago - By: AbbVie
AbbVie to Host Third-Quarter 2025 Earnings Conference Call
Please enable JavaScript to continue using this application.